Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c) Requena-Méndez, Ana et al., 2014
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/147900

Health policies to control Chagas disease transmission in European countries

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Chagas disease (CD) is a highly prevalent parasitic disease in immigrants from Mexico, as well as all of Central and South America. The total number of infected people is estimated between eight and ten million [1], [2], of whom 30%-40% either have, or will, develop cardiopathy, gastrointestinal disease, or both [1]. Cardiac involvement is the main cause of death from this infection through arrhythmias and cardiomyopathy. Nifurtimox and benznidazole are the only available medicines with proven efficacy against Trypanosoma cruzi infection in acute, congenital infection and early chronic infection. Until recently the treatment of chronic disease, particularly of adult patients with indeterminate form, was controversial; but during the past decade there has been a trend to offer treatment to adult patients and those with early cardiomyopathy.

Citació

Citació

REQUENA-MÉNDEZ, Ana, et al. Health policies to control Chagas disease transmission in European countries. PLoS Neglected Tropical Diseases. 2014. Vol. 8, num. 10, pags. e3245. ISSN 1935-2735. [consulted: 19 of August of 2026]. Available at: https://hdl.handle.net/2445/147900

Exportar metadades

JSON - METS

Compartir registre